TPM1 Gene Cardiomyopathy familial hypertrophic type 3 Genetic Test sale cost 4400 AED
PLN Gene Cardiomyopathy dilated type 1P Genetic Test sale cost 3200 AED PLN Gene Cardiomyopathy dilated type 1P Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.3,200 د.إCurrent price is: 3,200 د.إ.
PHOX2B Gene Central hypoventilation syndrome with or without Hirschsprung disease Genetic Test sale cost 4400 AED PHOX2B Gene Central hypoventilation syndrome with or without Hirschsprung disease Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

TPM1 Gene Cardiomyopathy familial hypertrophic type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “TPM1 Gene Cardiomyopathy Familial Hypertrophic Type 3 Genetic Test” is a specific diagnostic tool used to identify mutations in the TPM1 gene, which are linked to Familial Hypertrophic Cardiomyopathy Type 3 (FHCM3). This condition is a form of heart disease characterized by the thickening of the heart muscle, which can lead to various complications, including heart failure, arrhythmias, and sudden cardiac death. The TPM1 gene plays a crucial role in the contractile function of heart muscle cells, and mutations in this gene can disrupt this function, leading to the development of cardiomyopathy.

The test is performed at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities. The cost of the test is 4400 AED, making it an investment in personal health for those with a family history of cardiomyopathy or individuals displaying symptoms associated with the condition. By identifying the genetic mutation early, patients can benefit from tailored management strategies aimed at mitigating the progression of the disease and improving quality of life. This test is especially important for families affected by this condition, as it can provide crucial information for the management and potential prevention of the disease in at-risk family members.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TPM1 Gene Cardiomyopathy Familial Hypertrophic Type 3 Genetic Test

Components

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type

Cardiovascular Pneumology Disorders

Doctor

Cardiologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for TPM1 Gene Cardiomyopathy, familial hypertrophic type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPM1 Gene Cardiomyopathy, familial hypertrophic type 3 NGS Genetic DNA Test gene TPM1

Test Details

TPM1 gene cardiomyopathy, familial hypertrophic type 3 is a specific type of genetic disorder that affects the heart muscle. It is caused by mutations in the TPM1 gene, which provides instructions for making a protein called tropomyosin 1. This protein is involved in the regulation of muscle contraction.

Familial hypertrophic cardiomyopathy (FHC) is a condition characterized by the thickening of the heart muscle, particularly the walls of the left ventricle. This can lead to symptoms such as shortness of breath, chest pain, fatigue, and an increased risk of abnormal heart rhythms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the case of TPM1 gene cardiomyopathy, familial hypertrophic type 3, NGS genetic testing can identify mutations in the TPM1 gene that are associated with this specific form of cardiomyopathy.

By identifying these mutations, NGS genetic testing can help in the diagnosis of familial hypertrophic cardiomyopathy and provide valuable information for genetic counseling and management of the condition. It can also be used for predictive testing in at-risk individuals who have a family history of the disorder.

Overall, TPM1 gene cardiomyopathy, familial hypertrophic type 3 NGS genetic testing plays a crucial role in the accurate diagnosis and management of this specific form of cardiomyopathy.

Test Name TPM1 Gene Cardiomyopathy familial hypertrophic type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TPM1 Gene Cardiomyopathy, familial hypertrophic type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPM1 Gene Cardiomyopathy, familial hypertrophic type 3 NGS Genetic DNA Test gene TPM1
Test Details

TPM1 gene cardiomyopathy, familial hypertrophic type 3 is a specific type of genetic disorder that affects the heart muscle. It is caused by mutations in the TPM1 gene, which provides instructions for making a protein called tropomyosin 1. This protein is involved in the regulation of muscle contraction.

Familial hypertrophic cardiomyopathy (FHC) is a condition characterized by the thickening of the heart muscle, particularly the walls of the left ventricle. This can lead to symptoms such as shortness of breath, chest pain, fatigue, and an increased risk of abnormal heart rhythms.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced technology to analyze multiple genes simultaneously. In the case of TPM1 gene cardiomyopathy, familial hypertrophic type 3, NGS genetic testing can identify mutations in the TPM1 gene that are associated with this specific form of cardiomyopathy.

By identifying these mutations, NGS genetic testing can help in the diagnosis of familial hypertrophic cardiomyopathy and provide valuable information for genetic counseling and management of the condition. It can also be used for predictive testing in at-risk individuals who have a family history of the disorder.

Overall, TPM1 gene cardiomyopathy, familial hypertrophic type 3 NGS genetic testing plays a crucial role in the accurate diagnosis and management of this specific form of cardiomyopathy.

SKU: TEST-3403 Category:

Related products